Fig. 1From: Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathwayTemporal, spatial and blood-source gaps as a cause of residual malaria transmission. The gaps are not at scale. New interventions are needed to cover these gapsBack to article page